BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6459991)

  • 1. Genetic control of allogeneic interactions in the guinea-pig. IV. The specific elimination of MLC suppressor cells by the in vivo administration of antisera against a GPLA-B region-controlled determinant.
    Geczy AF; Coulits N
    Immunology; 1982 Jan; 45(1):139-45. PubMed ID: 6459991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic control of allogeneic interactions in the guinea-pig. V. Evidence for a dissociation between genes coding for A GPLA-B region-controlled determinant and genes coding for MLC suppressor cells.
    Geczy AF; Coulits N
    Immunology; 1983 Apr; 48(4):755-62. PubMed ID: 6219941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to guinea pig lymphokines. IV. Suppression of the mixed leukocyte culture reaction by anti-lymphokine globulin.
    Geczy CL; Geczy AF; De Weck AL
    J Immunol; 1976 Nov; 117(5 Pt.2):1824-31. PubMed ID: 136471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new mediator (suppressor cell induction factor) activating T cell-mediated suppression: characterization of suppressor cells, kinetics of their generation, and mechanism of their action.
    Kasakura S; Taguchi M; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1983 Nov; 131(5):2307-15. PubMed ID: 6226739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic control of allogeneic interactions in the guinea-pig. II. Evidence for alloantigen-specific suppressor cells in the guinea-pig mixed leukocyte culture.
    Geczy AF; Coulits N
    J Immunogenet; 1981 Apr; 8(2):139-49. PubMed ID: 6453165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activation of human suppressor cells: relative quantitation and specificity of suppressor cells generated in primary and secondary mixed lymphocyte cultures.
    Hess AD; Tutschka PJ; Santos GW
    Exp Hematol; 1981 Apr; 9(4):415-30. PubMed ID: 6453719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of human cytotoxic lymphocyte responses. I. Non-cytolytic suppression mediated by alloantigen-activated cells.
    Crosier PS; Broom BC
    Immunology; 1981 May; 43(1):11-8. PubMed ID: 6454646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
    Majlessi L; Bordenave G
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of human cytotoxic lymphocyte responses. II. Suppression by a soluble factor produced by primed lymphocytes.
    Crosier PS; Broom BC
    Immunology; 1981 May; 43(1):19-24. PubMed ID: 6454647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
    Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
    J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloantigen-specific prolongation of allograft survival in recipient mice treated by alloantigen immunization following ultraviolet-B irradiation.
    Hori T; Kuribayashi K; Uemoto S; Saito K; Wang L; Torii M; Shibutani S; Taniguchi K; Yagi S; Iida T; Yamamoto C; Kato T
    Transpl Immunol; 2008 Apr; 19(1):45-54. PubMed ID: 18346637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The major histocompatibility complex of the guinea-pig. II. Relationship between mixed leucocyte reactivity and serologically-defined phenotypes of the GPLA B locus and I region.
    Geczy AF; de Weck AL
    J Immunogenet; 1976 Jun; 3(3):191-8. PubMed ID: 61245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation.
    Comoli P; Ginevri F; Maccario R; Avanzini MA; Marconi M; Groff A; Cometa A; Cioni M; Porretti L; Barberi W; Frassoni F; Locatelli F
    Nephrol Dial Transplant; 2008 Apr; 23(4):1196-202. PubMed ID: 18029377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ CD25+ regulatory T cells in human pregnancy: development of a Treg-MLC-ELISPOT suppression assay and indications of paternal specific Tregs.
    Mjösberg J; Berg G; Ernerudh J; Ekerfelt C
    Immunology; 2007 Apr; 120(4):456-66. PubMed ID: 17229266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of a hybridoma T suppressor cell and suppressor factor.
    Niederhuber JE; Schook LB; Bingham EL
    Surgery; 1982 Aug; 92(2):146-52. PubMed ID: 6213051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune suppression in vivo with antigen-modified syngeneic cells. V. Interacting T cell subpopulations in the suppressor pathway.
    Sherr DH; Benacerraf B; Dorf ME
    J Immunol; 1980 Oct; 125(4):1862-8. PubMed ID: 6997388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.
    Maccario R; Podestà M; Moretta A; Cometa A; Comoli P; Montagna D; Daudt L; Ibatici A; Piaggio G; Pozzi S; Frassoni F; Locatelli F
    Haematologica; 2005 Apr; 90(4):516-25. PubMed ID: 15820948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
    Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK
    Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12.
    Okamoto I; Kohno K; Tanimoto T; Ikegami H; Kurimoto M
    J Immunol; 1999 Mar; 162(6):3202-11. PubMed ID: 10092771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV; Pettey CL; Collins JJ
    Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.